from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3470c/ilvB2

LFCtreatmentdescriptionclass of inhibitor

-0.190

Amikacinug/mL Amikacintranslation

1.262

Cap5-10ug/mL Capreomycintranslation

-0.468

Rox10-50 ug/mL Roxithromycintranslation

-0.765

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.283

Rif0.2-5ug/mL Rifampicintranscription

0.197

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.419

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.121

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.186

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.617

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.805

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.517

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.511

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.989

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.309

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.841

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.113

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.275

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.828

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.734

Nigericin50 uM Nigericinrespiration

-0.016

TRC10-150 ug/mL Triclosanrespiration

0.202

TRZ10-25 ug/mL Thioridazinerespiration

-0.642

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.359

menadione6-10 ug/mL Menadionerespiration

0.260

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.460

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.036

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.163

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.643

NRP_1Non-replicating persistence stage 1dosRassociated

-0.543

Amp0.2mg/mL AmpicillincellWall

-0.623

Cephalexin20-100 ug/mL CephalexincellWall

0.477

Cerulenin0.32-5 ug/mL CerulenincellWall

0.838

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.524

EMB10-20 ug/mL EthambutolcellWall

-0.368

Eta12-40 ug/mL EthionamidecellWall

-0.255

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.503

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.187

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.833

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

1.549

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.698

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.356

H2O24 mM hydrogen peroxideDNAdamaging

-0.340

Levo10 ug/mL LevofloxacinDNAdamaging

1.347

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.891

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.388

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.198

UVUV-irradiationDNAdamaging

-1.008

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.499

Antimycin12.5-50 ug/mL Antimycin A?

-0.686

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.302

PA_110-50 ug/mL Antitubercular compound PA-1?

0.352

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.087

PA8240.2-2 ug/mL PA-824?

0.459

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.212

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.418

Verapamil50 uM Verapamil?

-1.344

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.155

methoxatin10-20 ug/mL Methoxatin?